Townsend Adam J. Insider Trades

Insider Trading History

Track insider trading activity for Townsend Adam J.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.45M 84,050 shares
Last Trade
Jan 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.5k 695 shares
$29.52
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.48M 84,745 shares
Last Trade
Jan 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$101k 3,323 shares
$30.43
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.61M 88,068 shares
Last Trade
Jan 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$65.9k 2,201 shares
$29.96
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.7M 90,269 shares
Last Trade
Jan 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$77.1k 2,685 shares
$28.70
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.79M 92,453 shares
Last Trade
Feb 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$77.8k 1,148 shares
$67.77
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.84M 93,601 shares
Last Trade
Jan 29, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$58.1k 906 shares
$64.14
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.88M 94,507 shares
Last Trade
Jan 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$222k 3,413 shares
$65.00
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $4.11M 100,155 shares
Last Trade
Jan 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.29M 34,533 shares
$66.30
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $4.02M 97,920 shares
Last Trade
Jan 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$149k 2,235 shares
$66.81
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $7.65M 186,407 shares
Last Trade
Dec 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.77M 110,000 shares
$61.58
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $4.88M 118,850 shares
Last Trade
Dec 01, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.69M 110,000 shares
$60.81
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $7.08M 172,500 shares
Last Trade
Dec 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.77M 110,000 shares
$61.58
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $11.6M 282,500 shares
Last Trade
May 03, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$425k 5,000 shares
$85.02
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.12M 75,995 shares
Last Trade
May 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$414k 5,000 shares
$82.71
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.32M 80,995 shares
Last Trade
May 03, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$425k 5,000 shares
$85.02
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.12M 75,995 shares
Last Trade
Apr 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$370k 5,000 shares
$74.05
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.32M 80,995 shares
Last Trade
Apr 03, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$383k 5,000 shares
$76.68
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $11.8M 287,500 shares
Last Trade
Apr 03, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$383k 5,000 shares
$76.68
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $12M 292,500 shares
Last Trade
Mar 03, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$325k 5,000 shares
$64.98
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Commercial Officer
Holding Value $3.12M 75,995 shares
Last Trade
Mar 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$319k 5,000 shares
$63.84
$41.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up